Ring core-biotinylated testosterone tracers were synthesized with bridges of three different lengths connecting the biotin moiety to the steroid core (7␣-C n -Bio-T, n ‫؍‬ 3, 6, or 11). Together with a position 7-specific polyclonal anti-testosterone antibody, we used the 7␣-C 11 -Bio-T tracer to develop a novel, labeled-hapten competitive immunoassay for total testosterone in serum. (The C 3 and C 6 tracers proved to be not suitable for analogous immunoassays.) Enhanced chemiluminescence signal was generated by use of a second immobilized antibody and a streptavidin-horseradish peroxidase conjugate. The measuring range of the assay is 0.2-20.0 nmol/L, linearity of serial dilutions can be demonstrated, the lower detection limit is 0.125 nmol/L, and the interassay imprecisions are 13-16%. Accuracy determinations in mass spectrometry-controlled reference specimens showed a mean recovery of 95%. In addition, the assay shows low cross-reactivities, demonstrating the favorable specificity of the combination of a "nearly native" tracer with a position analog antibody. The optimized steric structure and the long spacer arm of the biotinylated testosterone tracer make this chemiluminescence assay well-suited for measuring total testosterone concentration in serum.
Nonisotopic immunoassays for the determination of steroids in serum are at present widely used in clinical laboratories [1, 2] . Besides limitations attributable to the competitive technique, another disadvantage must be considered: Use of enzyme-labeled steroid tracers may diminish the sensitivity and specificity of the assay when the structures of the tracers are altered by the derivatization method.
To address this problem, we developed novel biotinylated steroid tracers [3, 4] . Our concept, in accordance with Landsteiner's principle [5] that antibody specificity is directed primarily at that portion of the hapten furthest from the functional group linking it to the carrier protein, leads to an effective competition between the immunogen and the steroid tracer when the tracer is a ring corebiotinylated steroid. The biotin residue is attached via a defined spacer group to the steroid at the same position as the immunogen that was used to produce the specific anti-steroid antibody used in the assay. This synthetic approach leads one to expect high specificity because of the greater conformational similarity of the hapten to the native steroid.
The performance of these tracers is directly related to the chemical nature and length of the spacer arm. We previously demonstrated that not only the specificity but also the sensitivity (detection limit) of such an assay format is advantageous over original RIA techniques [4] by establishing a chemiluminescence immunoassay for estrone. This improvement was due to the high affinity of biotin to the streptavidin (sAv) 3 reporter enzyme conjugate, which can be used for an appropriate chemiluminescence substrate. However, the measuring range for estrone in serum could not be improved. We therefore believe that this concept is an attractive alternative to other non-RIA developments for steroid measurements.
To further confirm this concept, we have synthesized different sterically optimized ring core-biotinylated testosterone tracers-17␤-hydroxyandrost-4-en-3-one-7␣-(biotinyl)-6-N-propylamide (7␣-C 3 -Bio-T), -6-N-hexylamide (7␣-C 6 -Bio-T), and -6-N-undecylamide (7␣-C 11 -Bio-T) [6] -and subsequently developed a competitive testosterone (T) chemiluminescence immunoassay. Here we report the characteristics of the assay and its comparison with two commercially available RIAs.
Materials and Methods reagents
Chemicals. sAv-conjugated horseradish peroxidase (HRP) was obtained from Vector. [1, 2, 6, H]T (specific activity: 3.7 TBq/mmol) was from Amersham-Buchler. Androstenedione, 19-nortestosterone, and 5␣-dihydrotestosterone were from Fluka; 19-hydroxyandrostenedione and progesterone from Sigma; 5␣-androstanediol, 5␤-androstanediol, 11-keto-testosterone, 3␤,17␤-dihydroxy-5␣-androstane, 17␣-methyltestosterone, epitestosterone, and 11␤-hydroxy-testosterone from Research Plus, Bayonne, NJ. All other laboratory chemicals were from Merck. Antibodies and antibody-coated microtiter plates. The polyclonal rabbit anti-T antibody 7A [raised against T-7␣-(Ocarboxymethyl)-thioether-BSA] was obtained from Accurate Chemical, Westbury, NY (lot no. F9046, antibody titer 1:10 000). For capture antibody we used a goat anti-rabbit antibody from Biogenesis, Poole, UK (batch no. 960124D/ 961129D, concentration 2.7 g/L), coated to Microlite 2F wells (Dynatech). The coating procedure consisted of incubating 250 L of 50-fold-diluted capture antibody solution (54 mg/L) in assay buffer without BSA in the Microlite wells for 18 h at room temperature. After the wells are washed with borate washing buffer, they are incubated with 200 L of assay buffer plus 20 g/L BSA for 30 min at 37°C in a shaker-incubator. After additional washing, the wells are ready to use or can be stored in a dry place for up to 4 weeks.
Tracers. As described in detail for 7␣-C 6 -Bio-T [6] , the synthesis for the biotinylated tracers started from 6dehydrotestosterone 17␤-acetate, which was alkylated at the 7-position in a 1,6-Michael addition reaction by applying 6-(tert-butyldimethylsilyloxyalkyl) bromide Grignard reagents. After cleavage of the respective silyl ethers, the HPLC-isolated 7␣-isomers of the alcohols were trans-formed to primary amines and subsequently biotinylated with biotinyl-N-hydroxysuccinimide ester.
Calibrators. T calibration specimens were prepared by dissolving T (from Merck, lot no. K 02983215, purity Ͼ98%) in 960 mL/L ethanol (storable at Ϫ70°C) and diluting to the following final concentrations in assay buffer: 0.2, 0.5, 1.0, 2.0, 5.0, 10, and 20 nmol/L (equivalent to 10, 25, 50, 100, 250, 500, and 1000 fmol/well). The lyophilized control samples (I-III) for T were based on a human serum matrix (to be reconstituted with 3 mL of distilled water) and checked for T content by a definitive mass spectrometry (MS) method [7] .
serum specimens
Blood was taken from 96 patients (both sexes) and from 74 apparently healthy men and pre-and perimenopausal women. All subjects gave their informed consent to the investigation according to the standards of the Ethics Committee of the Technical University Munich. Health was assumed on the basis of a medical and clinical chemistry examination. Premenopausal women were regularly menstruating. A perimenopausal status was presumed in case of the following serum constellation: luteinizing hormone Ͻ20 IU/L, follicle-stimulating hormone Ͻ30 IU/L, estradiol Ͼ120 pmol/L. All sera were stored at Ϫ70°C after centrifugation. For measurements, 250-L serum samples were extracted with 1.5 mL of diethyl ether. The aqueous phase was frozen in a CO 2 /ethanol mixture, and the extract was removed and evaporated in a stream of N 2 . The residue was subsequently reconstituted in 250 L of assay buffer. Recovery of T was reproducible at 89 -92%, as checked by analyzing 3 different serum pools that had been supplemented with various amounts of tritiated T (up to 50 nmol/L). The measured counts of 3 ϫ 7 samples after extraction were referred to those in the respective unextracted samples measured on 3 separate days. The final T values found with the assay were therefore corrected by the above extraction factor (multiplied ϫ 10/9).
procedures Assay protocol. The following final concentrations (in assay buffer) of the key components were used: 7A antibody, 1:600; sAv-conjugated HRP, dilution 1:20 000 (50 g/L); 7␣-C 11 -Bio-T tracer, 3.0 nmol/L (600 fmol/well). The assay procedure was performed as described previously [4] , with 50 L of specimen/calibrator and 150 L of tracer stock solution. Total assay time is ϳ5 h, with the incubation steps taking a total of 2.5 h.
Displacement experiments. The technique for controlling the degree of T displacement by the 7␣-Bio-T tracers was equivalent to that described previously [4] . In brief, serial dilutions of antibody solution (1:10 2 to 1:10 5 ) were incubated with 7␣-Bio-T (C 3 -, C 6 -, or C 11 -tracer; 0 to 35 nmol/L each) and tritiated T (3.5 nmol/L). The percent binding (%B) of tritiated T after separation of bound from free label was plotted vs log of antibody dilution for different tracer concentrations. At a given antibody dilution, the difference in %B values in the presence or absence of the respective tracer is represented by d, with the highest d values indicating optimal antibody titers. At various 7␣-Bio-T concentrations and at the optimum antibody dilution, the ratios of %B (7␣-Bio-T concn Ͼ0) to %B (7␣-Bio-T concn ϭ 0) are then calculated and plotted against the tracer concentration. The 7␣-Bio-T concentration at which 50% of the bound tritiated T is displaced (%B rel ϭ 50%) reflects the molar ratio of the respective biotinylated tracer and tritiated T for competition. analytical performance of the chemiluminescence immunoassay Accuracy. Accuracy testing was performed by adding known amounts of T to 3 pooled serum samples with low endogenous T content. The concentrations were measured before and after addition of T and recoveries were calculated. Additionally, 3 control materials with different T concentrations were tested in measurements on separate days and compared with the results of a definitive MS method. These samples were extracted before use in the same way as the serum specimens.
Precision. Different serum pools were used to determine the intraassay and the interassay CVs.
Lower detection limit. The threshold for detection of T was calculated as the concentration corresponding to the mean ϩ 3 SD of the light intensity for zero T, measured in 20 serial (intraassay) determinations.
Functional sensitivity. The functional sensitivity was assessed [8, 9] by repeated interassay measurements of specimens with T at 0.2, 0.5, 1.0, 1.5, 2.0, and 3.0 nmol/L (n ϭ 12). Interpolation of the minimum analyte concentration at a CV of 20% from the precision-dose profile was used to define the minimum detection limit.
Linearity. Dilution linearities were tested by consecutively diluting 8 sera with high endogenous T concentrations; the measured T concentrations, pmol/well, were plotted against the effective sample volumes in microliters.
Cross-reactivity. The calculation of percent cross-reactivities for the different antibodies was made according to Abraham [10] and expressed as the ratio of the apparent T concentrations to the added concentration of cross-reacting steroid at 50% binding of an almost T-free serum sample.
Results

preparation of the biotinylated t tracers and displacement experiments
The 7␣-Bio-T immunochemical tracers ( Fig. 1 ) were prepared by attaching biotin via C 3 -, C 6 -, and C 11 -alkyl spacer arms at the C-7 position of T as described above.
The degree of competition between the three different T tracers and the endogenous steroid at the binding site of the polyclonal rabbit anti-T antibody was investigated in displacement experiments. Examining the correlation between the difference values d and the log of antibody concentrations, we determined that the optimal 7A dilution, at which 50% of the [ 3 H]T is bound, was 1:200, independent of the tracer concentrations. All three tracers displaced the tritiated T (3.5 nmol/L) from the binding site of the antibody in a competitive manner at different molar ratios: 3.0 nmol/L for 7␣-C 3 -Bio-T, 8.5 nmol/L for 7␣-C 6 -Bio-T, and 17.0 nmol/L for 7␣-C 11 -Bio-T.
signal generation
For optimal signal generation in the chemiluminescence immunoassay system with the 7␣-C 11 -Bio-T tracer, the best 7A antibody dilution for the coated wells was found to be 1:600. For a dynamic assay range of 0.2-20.0 nmol/L T, the C 11 long-chain tracer was best in a 3.00 nmol/L (600 fmol/well) final concentration.
The 7␣-C 3 -Bio-T tracer was not suitable for establishing a chemiluminescence assay because of lack of binding to the sAv-linked HRP. The impaired signal generation was such that no decline of the %B values below 80% in the dose-response curve could be recorded. The 7␣-C 6 -Bio-T tracer showed similar characteristics. A direct comparison of the maximum light intensities (T ϭ 0 nmol/L) was performed for the C 6 -and C 11 -tracers (1.5 and 3.0 nmol/L, respectively) with the conditions for the 7␣-C 11 -Bio-T assay. Whereas 8000 -8500 relative light units were measured for 7␣-C 11 -Bio-T, only 180 -220 units were counted for 7␣-C 6 -Bio-T; nevertheless, a complete dose-response curve from 100% to 25% B could be calculated when measuring all T calibrators. By using affinity-purified 7A antibody [6] for a 7␣-C 6 -Bio-T assay, binding to the coated microtiter plate wells was improved, which thus improved the assay signal. The performance data of that assay, however, were less satisfying than for the 7␣-C 11 -Bio-T assay because of unfavorable signal-to-noise characteristics (data not shown). assay performance data Figure 2 shows the calibration curve of the assay for known amounts of T in assay buffer. Mean values Ϯ 2 SD for 10 interassay determinations of the calibrators are also given. The lowest T concentration that was significantly different from zero was 6.5 fmol/well (equivalent to a serum concentration of 0.125 nmol/L).
The measured T concentrations for control samples (I-III) are presented in Table 1 . The chemiluminescence immunoassay measured T at 95% of the values found by the MS method. The analytical recoveries of T added to sera with low T content were 95-104% (Table 1) .
Intra-and interassay imprecisions, assessed from the SD of multiplicates of various serum samples with low, medium, and high T content (4 pool sera for intraassay and interassay imprecisions), are summarized in Table 2 . Figure 3 shows the precision-dose profile of various T values determined in measurements on separate days in the lower range to assess the minimum detection limit. At a CV of 20% the T value was 0.8 nmol/L. The functional sensitivity is ϳ6 times the lower detection limit.
For 8 sera with different endogenous T contents, the linearities of dilutions were determined (Fig. 4) . The data for 50% inhibition points and respective cross-reactivities of a series of putative cross-reacting steroids are presented in Table 3 for the 7A antibody and both of the RIA antibodies. Because of the extraction step, no interferences were observed in hemolytic sera, sera containing increased lipoproteins, or sera from patients with either hyperbilirubinemia or monoclonal hypergammaglobulinemia (data not shown).
measurements of t serum concentrations in adults
The mean values, SD, and 95% ranges of T concentrations in 74 sera from healthy men and pre-/perimenopausal women are given in Table 4 . 
intermethod comparisons
We compared the results for T concentrations by the chemiluminescence assay in 170 sera with those by two 125 I-RIA kits (from DPC and ICN). All linear regression parameters, determined according to Passing and Bablok [11] , and Spearman correlation coefficients are given in Table 5 for the whole concentration range up to 29 nmol/L, and for the ranges 0.4 -3.0 and 8.0 -29 nmol/L. Fig. 5 (top) shows the paired values for DPC vs the 7␣-C 11 -Bio-T assay. In Fig. 5 (bottom) a Bland-Altman plot [12] depicts the difference between both methods vs the mean values.
Discussion
The determination of T as the key androgen steroid in human serum is of great importance in the endocrinological laboratory, especially in the evaluation of hyperandrogenemic states in women. T is circulating primarily in bound form, mostly to sex-hormone-binding globulin (SHBG), only 1-2% being unbound [13, 14] . Hitherto nonradioactive T immunoassays reported were neither entirely specific for this steroid alone, nor as sensitive as RIA methods [15] . However, recent developments give fair promise that new nonisotopic assays will have superior performance data for measuring T in serum. A recently evaluated automated direct chemiluminescence immunoassay from Chiron ACS:180 seems to be particularly attractive as a routine assay [16, 17] . By using a conventionally synthesized T tracer (an acridinium ester labeled to position 3) and a position 3-complementary rabbit anti-testosterone antibody for the competitive assay format, this immunoassay is probably subject to crossreactivity with an unidentified steroid compound; this is seen when comparing the ACS results with a GC-MS method [18] . Other novel automated T immunoassays have been developed by DPC (Immulite system) and by Boehringer Mannheim (Elecsys system). External evaluations of these assays have still to be described. Thus, the versatile and reliable application of nonisotopic immunoassays in various endocrine disease states is still in debate [19] . Identification of hyperandrogenemia in women, for example, requires highly accurate and precise measurements of total or free (non-SHBG-bound) T concentrations in serum [14] .
We have developed and used "nearly native" tracers, which possess an optimized ability to compete with analyte molecules, thanks to the attachment point we used. As an alternative approach to the problem inherent in use of the steroids' functional groups to attach reporter groups to these molecules, we inserted a prosthetic biotin label in a steroid ring core position furthest from the critical functionalized positions. However, the characteristics of tracers of this nature are also related to the chemical nature and length of the spacer arm. As Bieniarz et al. [20] have shown, an extended length of spacers between the reporter enzyme and antibody conjugates for different protein analytes leads to a marked increase in signal strength when increasing the length of the linker from 9 to 30 atoms. In light of these data, we investigated different analogs of the 7␣-Bio-T tracers, using various spacer lengths to improve the signal generation. The addition of a prefunctionalized Grignard compound at the C-7 position is the key step of the tracer syntheses and offers the possibility of inserting CH 2 -groups in various lengths to 6-dehydrotestosterone, which is advantageous for modeling different immunochemical tracers. The signal-generation step of the antibody-bound 7␣-Bio-T/sAv-coupled HRP system is affected by the length of the linker, the lowest light intensities being achieved with 7␣-C 3 -Bio-T and the greatest with 7␣-C 11 -Bio-T. Steric hindrances possibly interfere with the bipolar binding of the tracer to the antibody and to the sAv-HRP when the spacer arm length is insufficient. Care must be taken that the spacer not be too long, however, to avoid potential loss in antibody binding through the diminished hydrophilic character of the tracer. These considerations are supported by investigations of Tiefenauer and Andres [21] , who also discussed structural requirements of biotinyl-estradiol derivatives for optimal antibody binding.
As expected, displacement experiments depicted that the 7␣-Bio-T tracers displace tritiated T from the antibody in a competitive manner. 7␣-C 3 -Bio-T had the lowest displacement concentration at an equimolar ratio to tritiated T. For the two long-chain T tracers, the concentrations required to displace 50% of the [ 3 H]T increased markedly with the linker length. This may reflect the diminished hydrophilicity of the long-chain tracers. Especially remarkable are the performance data of the assay concerning the lower detection limit (0.125 nmol/ L), the excellent dilution linearity and recovery data, and the functional sensitivity (0.8 nmol/L). Suitability of the minimum detection limit for specimens with T values in the female reference range can thus be assumed. The accuracy of the assay with MS-defined control specimens [7] reveals a well-acceptable 95% recovery.
Differences were observed in the 12 potentially crossreacting C 19 steroids with regard to the antibodies of the different assays (7A, ICN, DPC). Overall, the data for the 7A and the DPC antibodies were similar, whereas greater cross-reactivities were observed with the ICN antibody (Table 3 ). This finding reflects the influence of the different bridge positions on specificity during antibody formation. The ICN assay uses a rabbit anti-T antibody (immunogen T-19-(O-carboxymethyl)ether-BSA) and a T molecule as tracer that is 125 I-substituted at the C-19 position. The DPC assay uses a coated rabbit anti-T antibody; additional information concerning the immunogen and the 125 I-T tracer is not available, but we presume a position 3-or 7-immunogen and a respective position analog tracer. In particular, 19-nor-and 17␣-methyl-T have quite similar low cross-reactivities with the 7A and DPC antibodies, in contrast to a very high cross-reaction with the ICN antibody. The cross-reactivity of androstenedione, present in relevant concentrations in serum, was the only one that was greater for the 7A antibody than for the other two antibodies; nevertheless, this crossreaction (1.6%) is still quite acceptable.
These characteristics allow the sensitive and reproducible determination of T over a large dynamic range with the chemiluminescence assay. Although the assay requires a serum extraction step before measurement, its handling is easy and the reagents have a long shelf-life. Results are available within 5 h.
Applying the 7␣-C 11 -Bio-T assay to measure T concentrations in 74 sera from healthy adults gave results (Table  4 ) in accordance with reference values given in literature [24, 25] . Intermethod comparisons with two commercially available nonextraction RIAs yielded acceptable correlations in the ranges 0 -29 (all), 0 -3.0 (female), and 8 -29 nmol/L (male) T. Correlations with the DPC method are given in Table 5 and Fig. 5 (top) . At low concentrations the DPC results are lower than and less well correlated (r ϭ 0.7119) with the 7␣-C 11 -Bio-T assay results-findings confirmed by the Bland-Altman plot (Fig. 5, bottom) . With increasing T concentrations, however, no relevant divergences between the two methods could be found.
The performance characteristics of the 7␣-C 11 -Bio-T assay are similar to those of the two RIAs, the latter showing comparable precision and recovery data ( Table 6 ). Accuracy measurements with MS-defined control materials showed comparable results for DPC, whereas ICN had lower recoveries (80%). The lower detection limit of the DPC was equal to that of the chemiluminescence assay. In the DPC kit information, an intraassay precision-dose profile presents a functional sensitivity of ϳ0.7 nmol/L. This is also comparable with the minimum detection limit of the 7␣-C 11 -Bio-T assay.
In conclusion, the determination of total T in serum with the 7␣-C 11 -Bio-T tracer in an HRP-labeled, ligand-binding chemiluminescence assay offers good sensitivity and specificity and is easy to use. However, the imprecision still needs to be improved. The superior performance data of the 7␣-C 11 -Bio-T assay demonstrate the importance of an optimized steric structure and a long spacer arm of the biotinylated T tracers. In addition, the 7␣-C 11 -Bio-T tracer provides higher specificity through better availability of the critical antigen sites, in accordance with suggestions by Fránek [24] . a Quoted from data accompanying the kit. b Our data. c Accuracy measurements were performed with the MS-defined control specimens (n ϭ 4). d T concentration, nmol/L, of determination is listed in parentheses.
